Work

Radiopharmaceutical supply disruptions and the use of 99mTc-hydroxymethylene diphosphonate as an alternative to 99mTc-pyrophosphate for the diagnosis of transthyretin cardiac amyloidosis: An ASNC Information Statement

Year: 2022

Type: article

Source: Journal of Nuclear Cardiology

DOI: 10.1007/s12350-022-03059-5

Authors: Edward J. Miller, Roxana Campisi, Nishant R. Shah, Sean McMahon, Sarah Cuddy, Cesia Gallegos-Kattan, Mathew S. Maurer, Thibaud Damy, Riemer H.J.A. Slart, Ketan Bhatia, Andrew J. Einstein

Institutions: Yale University, Instituto Argentino de Diagnóstico y Tratamiento, Diagnostico Maipú, Brown University, Hartford Hospital, Brigham and Women's Hospital, Harvard University, NewYork–Presbyterian Hospital, Columbia University Irving Medical Center, Université Paris-Est Créteil, University Medical Center Groningen

Language: English

Topic: Amyloidosis: Diagnosis, Treatment, Outcomes

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: bronze

Funders: National Institutes of Health, National Center for Advancing Translational Sciences

Award: Yale Clinical and Translational Science Award

OpenAlex ID: W4285493540

FWCI: 1.63

Cites: 30

Cited by: 29

Related to: 10